European Journal of Medicinal Chemistry (2019)
Update date:2022-07-29
Topics:
Wei, Huiqiang
Duan, Yuqing
Gou, Wenfeng
Cui, Jie
Ning, Hongxin
Li, Deguan
Qin, Yong
Liu, Qiang
Li, Yiliang
Tyrosine kinase inhibitors (TKIs) have achieved substantial clinical effects for cancer treatment while causing a number of adverse effects. Since hypoxia is an intrinsic difference between solid tumor and healthy tissues, one strategy to overcome the adverse effects of TKIs is to enhance the specificity of anti-tumor activity by selectively targeting hypoxic region of tumors. Herein, we designed and synthesized a series of novel 4-anilinoquinazoline derivatives by introducing 3-nitro-1,2,4-triazole group to the side chain of vandetanib with modification of aniline moiety. Lead compounds, 10a and 10g, exhibited potent inhibitory activity against EGFR and VEGFR-2 kinase. Moreover, these two compounds were shown to enhance anti-proliferative activities on A549 and H446 cells under hypoxic conditions compared to vandetanib and dramatically down-regulate VEGF gene expression. In vivo studies confirmed that 10a and 10g not only inhibited tumor growth in A549 xenografts of BALB/c-nu mice but also significantly reduce toxicity associated with weight loss compared to vandetanib. These results suggest that EGFR/VEGFR-2 dual inhibitors, 10a and 10g, emerged as potential hypoxia-selective anti-tumor drugs with less toxicity for inhibiting in vitro and in vivo models of non-small cell lung cancer cells.
View MoreWuhan Hanye Chemical New Material Co.,Ltd
Contact:+86-27-85308141
Address:LiuDian, Panlongcheng Economic Development Zone, HuangPi district, Wuhan, Hubei 430311 P.R.China
Jiangsu Willing Bio-Tech Co ltd
website:http://www.willingbio.com/
Contact:+86 18796909136--
Address:No 18 Guoqiao Road
website:http://www.chemdow.com
Contact:0086-10-82435335
Address:Room 401,Unit 3,4th Floor,Shangdijiayuan,Shangdi East Road, Haidian District,Beijing
Contact:+86-20-32051076
Address:1105,Building A, International Business Incubator,Science City
Contact:+86-10-62651721
Address:29 Yongxing Road, Daxing District,Beijing China
Doi:10.1016/j.tetlet.2008.05.155
(2008)Doi:10.1002/mrc.1270170305
(1981)Doi:10.1007/BF00952889
(1986)Doi:10.1016/j.jorganchem.2008.05.009
(2008)Doi:10.1016/S0040-4020(01)99047-7
(1966)Doi:10.1039/b912042d
(2010)